Human Genome Science
Human Genome Sciences outperform – New Analyst Rating from Robert W. Baird & Co. Incorporated
Friday, July 23rd, 2010Human Genome (HGSI) Upgrade from Neutral to Outperform – Analyst rating from Robert W. Baird
Thursday, July 22nd, 2010Human Genome Sciences outperform – New Analyst Rating from Robert W. Baird & Co. Incorporated
Thursday, July 22nd, 2010Human Genome ( HGSI ) Upgrade from Neutral to Outperform($32) – Analyst rating from Robert W. Baird
Thursday, July 22nd, 2010Human Genome ( HGSI ) Initial Recommendation Outperform – Analyst rating from RBC Capital Mkts
Wednesday, January 27th, 2010Human Genome (HGSI) Initial Recommendation – Outperform – Analyst rating from RBC Capital Mkts
Wednesday, January 27th, 2010Human Genome Sciences neues Kursziel – New Analyst Rating from UBS AG
Friday, January 15th, 2010Human Genome Sciences Downgrade – New Analyst Rating from Goldman Sachs Group Inc.
Tuesday, January 12th, 2010Human Genome Sciences Downgrade – New Analyst Rating from Goldman Sachs Group Inc.
Monday, January 11th, 2010Human Genome Sciences dabeibleiben – New Analyst Rating from Der Aktionaer
Tuesday, January 5th, 2010Human Genome Sciences dabeibleiben – New Analyst Rating from Der Aktionaer
Monday, January 4th, 2010Human Genome Sciences overweight – New Analyst Rating from Morgan Stanley
Tuesday, December 22nd, 2009Human Genome Sciences neues Kursziel – New Analyst Rating from Citigroup Corp.
Tuesday, December 1st, 2009New Analyst Rating from JP Morgan Chase & Co. – Human Genome Sciences overweight
Saturday, October 31st, 2009New Analyst Rating from JP Morgan Chase & Co. – Human Genome Sciences overweight
Friday, October 30th, 2009Human Genome Sciences buy
Saturday, January 26th, 2008Piper Jaffray stufen die Aktie von Human Genome Sciences von “neutral” auf “buy” hoch. Das Kursziel wird von 11 auf 9,00 USD gesenkt.
Human Genome Sciences outperform
Saturday, January 26th, 2008Bear Stearns stufen die Aktie von Human Genome Sciences von “peer perform” auf “outperform” hoch.
Human Genome Sciences neues Kursziel
Saturday, January 26th, 2008UBS stufen die Aktie von Human Genome Sciences unverändert mit “buy” ein. Das Kursziel wird von 17 auf 7,50 USD gesenkt.
Human Genome Sciences Downgrade
Saturday, January 26th, 2008Die Analysten von Merrill Lnch stufen die Aktie von Human Genome Sciences von “buy” auf “neutral” zurück.
Human Genome Sciences neues Kursziel
Saturday, January 26th, 2008JMP Securities stufen die Aktie von Human Genome Sciences unverändert mit “market outperform” ein. Das Kursziel wird von 15 auf 9,00 USD gesenkt.
Human Genome Sciences buy
Friday, January 11th, 2008Human Genome Sciences unverändert mit “buy” ein. Das Kursziel wird bei 17 USD gesehen.
Human Genome Sciences buy
Friday, January 11th, 2008UBS stufen die Aktie von Human Genome Sciences unverändert mit “buy” ein. Das Kursziel wird bei 17 USD gesehen.





